Doctorpresso to Launch AI-Powered Therapy Earbuds at CES 2026

Doctorpresso, a leading AI mental health technology company, will unveil Therapods at CES 2026 in Las Vegas. Billed as the world's first AI-powered earbuds for virtual group therapy, the device delivers real-time emotion sensing and group interaction analysis at a fraction of traditional therapy costs. The global mental health system continues to face significant challenges, with traditional barriers including cost, stigma, and limited access leaving wide gaps in care.

Therapods integrate advanced AI and multimodal biosensing to track voice patterns, brainwaves, and heart rate variability, delivering real-time emotional insights with more than 90% accuracy. By restoring critical nonverbal cues often lost in remote therapy, the device addresses one of the biggest challenges in virtual mental healthcare. The technology has received notable industry validation, earning a finalist position for the 2025 GLOMO Awards at Mobile World Congress.

Therapods aim to bridge care gaps by offering a scalable solution that delivers personalized emotional insights while maintaining clinical-grade security and privacy standards. At CES 2026, attendees will experience firsthand demonstrations of Therapods' emotion-sensing and virtual group therapy applications, highlighting its potential to reshape digital mental healthcare. Doctorpresso's work has been recognized across the industry, with achievements ranging from peer-reviewed studies to global award nominations.

The company is exploring partnerships with corporations, telemedicine providers, and educational institutions to broaden Therapods' reach. Its long-term vision is to establish a preventive mental health ecosystem where emotional wellbeing becomes a seamless part of everyday life. At CES 2026, Doctorpresso will announce new collaborations and showcase how Therapods technology can be adopted across industries, reinforcing its position as a global leader in AI-powered healthcare innovation.